HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes.

Abstract
Dysregulation of glucagon secretion plays an important role in the pathogenesis of type 2 diabetes (T2DM). However it hasn't been elucidated involvement of glucagon dysregulation in pathophysiology of T2DM. Recently a new glucagon sandwich enzyme-linked immunosorbent assay (ELISA) became available that can measure plasma glucagon level with higher accuracy and simpler procedure than the conventional RIA method. We performed OGTT for adult subjects aged 20-69 years to define normal glucose tolerance (NGT, n = 25), borderline glucose intolerance (defined as pre-diabetes mellitus: preDM, n = 15), or diabetes mellitus (DM, n = 13), and we measured glucagon levels with this new ELISA method at fasting and during OGTT. Plasma glucose, insulin, glucagon and active GLP-1 were also measured. This study took place in diabetes outpatient clinic in Kitasato University Hospital and an affiliated outpatient clinic. PreDM and DM exhibited higher fasting plasma glucagon levels than NGT (34.4 ± 4.6 and 44.1 ± 5.0 vs. 20.6 ± 3.6 pg/mL), and statistical significance was observed between NGT and DM (p < 0.05). There was significant correlation between fasting glucagon level and indexes of insulin sensitivity. During OGTT, glucagon levels were less suppressed in DM and preDM than in NGT, whereas no apparent relationship was observed between glucagon and GLP-1 secretion. Significant positive correlation was observed between glucagon levels during OGTT and fasting TG. In conclusion, subjects with mild T2DM exhibited fasting hyperglucagonemia and insufficient suppression to oral glucose load compared to NGT subjects.
AuthorsRaishi Ichikawa, Koji Takano, Kazumi Fujimoto, Tetsuya Motomiya, Masaki Kobayashi, Tadahiro Kitamura, Masayoshi Shichiri
JournalEndocrine journal (Endocr J) Vol. 66 Issue 8 Pg. 663-675 (Aug 29 2019) ISSN: 1348-4540 [Electronic] Japan
PMID31142688 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Blood Glucose
  • Glucagon
  • Glucose
Topics
  • Adult
  • Aged
  • Blood Glucose (drug effects, metabolism)
  • Diabetes Mellitus, Type 2 (metabolism, pathology)
  • Female
  • Glucagon (blood, metabolism)
  • Glucose (pharmacology)
  • Glucose Intolerance (blood, metabolism)
  • Glucose Tolerance Test
  • Humans
  • Insulin Resistance
  • Male
  • Middle Aged
  • Prediabetic State (metabolism, pathology)
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: